Avid Bioservices Inc (CDMO)

[entdoc]

hypi, I enjoy your posts. You said, "without a partner the odds are very slim that they will make this a reality", which has been said here many times in many ways, and in the past might have been true, but at this point there is enough interest in this sector, and in the PPHM anti-PS/apoptosis niche, that positive results on Sunrise (and even on peripheral projects) will inevitably buoy the stock price...with or without a partner. The biggest risk at this point is the appearance of an H-bomb cancer killer. For years I have been of the opinion that PPHM is an arms-length de facto R&D arm of a large pharma, and the commercial arm of UTSW, and have not changed my mind. Can you think of a less expensive way to do R&D on a product such as Bavi?